AES
39
-2
EIX
47
-11
DUK
60
5
LNC
28
-2
MRK
30
-3
HRB
37
2
AMP
52
6
CNP
47
6
LOW
39
5
AIG
32
-3
LMT
29
7
VRSK
56
16
ETN
69
2
CTAS
49
4
STI
10
-13
ALLE
19
3
JCI
45
4
TROW
37
5
WEC
48
7
VMC
33
3
AES
39
-2
EIX
47
-11
DUK
60
5
LNC
28
-2
MRK
30
-3
HRB
37
2
AMP
52
6
CNP
47
6
LOW
39
5
AIG
32
-3
LMT
29
7
VRSK
56
16
ETN
69
2
CTAS
49
4
STI
10
-13
ALLE
19
3
JCI
45
4
TROW
37
5
WEC
48
7
VMC
33
3
Financhill
Back

FTI Consulting Vs. Janux Therapeutics Industry Stock Comparison

Sell
42

FCN
FTI Consulting

Last Price:
$194.24
Seasonality Move:
8.91%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
42
FTI Consulting (FCN) is a Sell

Is FTI Consulting a Buy, Sell or Hold?

  • The current FTI Consulting [FCN] share price is $194.17. The Score for FCN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • FCN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCN Stock Price Chart

What is FTI Consulting's stock price today?

  • The FTI Consulting share price today is $194.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCN is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

FCN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.48 Sell
Relative Strength Index (14 RSI): 46.47 Sell
Chaikin Money Flow: 128175 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (191.69 - 200.23) Sell
Bollinger Bands (100): (197.19 - 224.43) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

FCN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 191.71 Buy
20-day SMA: 194.64 Sell
50-day SMA: 198.13 Sell
200-day SMA: 213.3 Sell
8-day EMA: 192.58 Buy
20-day EMA: 194.45 Sell
50-day EMA: 199.95 Sell
200-day EMA: 208.21 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

FTI Consulting Earnings Growth & FCN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $1.36 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

FTI Consulting Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):